Nigerian Pharma Stocks Create Millionaires in 2025 Amid Industry Transformation

In 2025, Nigerian pharmaceutical stocks witnessed a remarkable surge, leading to the emergence of new millionaires. The industry saw a radical shift following the exit of global giants like GlaxoSmithKline and Sanofi, resulting in a multi-billion naira supply gap for essential drugs.

Local players like Fidson Healthcare and Mai Baker capitalized on this opportunity, with Fidson delivering a 210% year-to-date return. The implementation of a presidential executive order to reduce product costs and boost local manufacturing further fueled the industry's growth, with some drugmakers experiencing a 369% surge in share prices.